heartburn and tirzepatide relief Tirzepatide Acid Reflux & Zepbound: GLP-1

Weight loss and short-chain fatty acids reduce systemic inflammation in monocytes and adipose tissue macrophages from obese subjects

GLP-1 regimens can contribute to reduced dietary intake and quality and may amplify risks of micronutrient shortfallsespecially in populations already susceptible to low vitamin and mineral intake, including women of childbearing age, older adults, and individuals on a low-calorie diet

This phenomenon is largely caused by the decrease in estrogen levels, which causes the hypothalamus (the part of the brain that regulates body temperature) to become more sensitive to slight changes in body temperature

Unlike inhaled medications that directly contact the oropharyngeal mucosa, tirzepatide is administered subcutaneously and acts systemically through incretin receptor pathways